Xconomy National

by in

Entry	Author	Date	Location
Another $15.2M for Proteon	Erin Kutz	08/12/11	Boston
Amag Pharma Cutting 68 Jobs	Ryan McBride	11/01/10	Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News	Erin Kutz	07/09/10	Boston
AlloCure, With Stem Cell Therapy for Kidney Failure, Arrives in New England with New CEO	Luke Timmerman	07/06/10	Boston
Medify, Incubated at Voyager Capital, Raises $1.3M to Reshape Health IT for Consumers	Gregory T. Huang	07/01/10	Seattle
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders	Ryan McBride	05/13/10	Boston
Amag Pharma to Sell 3M Shares	Ryan McBride	01/20/10	Boston
Genzyme Resumes Shipments of Gaucher’s Drug from Allston Plant	Ryan McBride	12/01/09	Boston
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says	Luke Timmerman	11/18/09	Boston
Amira Pharmaceuticals’ Experimental Lung Disease Drug May Have Legs	Denise Gellene	07/01/09	San Diego
Proteon Fills Coffers with $38M Round, Inks Deal for Potential Sale to Novartis	Ryan McBride	03/05/09	Boston
AMAG Pharma Awaiting FDA Word on New Iron-Replacement Drug	Ryan McBride	02/04/09	Boston
Genzyme Shares Climb as Competing Kidney Drug Stumbles	Luke Timmerman	01/27/09	Boston
Page 1 of 1